I. A. Klenina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
I. A. Klenina has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Oksana Petishko
Institute of Gastroenterology of NAMSU, Dnipro, Ukraine
24 shared publications - O. M. Tatarchuk
State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, Ukraine
22 shared publications - Yu. M. Stepanov
Institute of Gastroenterology of NAMSU, Dnipro, Ukraine
18 shared publications - V. I. Didenko
Institute of Gastroenterology of NAMSU, Dnipro, Ukraine
10 shared publications - L. M. Mosiichuk
State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, Ukraine
8 shared publications - Maryna Stoikevych
Institute of Gastroenterology of NAMSU, Dnipro, Ukraine
6 shared publications
Latest Publications
- Open Access
- 27 May 2026
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 60 (2) , 126-132
Metabolic profile in military personnel with inflammatory bowel disease
Background. The purpose of the study was to assess the indicators of lipid and carbohydrate metabolism, cortisol, leptin, and their relationships in military personnel with inflammatory bowel disease and metabolic syndrome. Materials and methods. The study included 40 military personnel with inflammatory bowel disease, who were divided into 2 groups: group I comprised 32 participants without metabolic syndrome, and group II included 8 patients with metabolic syndrome. The control group consisted of 10 apparently healthy individuals. Serum lipid parameters, glucose, insulin, cortisol, and leptin levels were measured. Insulin resistance was assessed using the HOMA-IR index. Results. All patients with inflammatory bowel disease demonstrated elevated serum cortisol compared to the control group (p < 0.05), with no significant difference between the study groups. Leptin levels in group II were 2.4-fold higher than in the control group, amounting to 6.25 (4.0; 16.2) ng/mL versus 2.65 (0.45; 3.9) ng/mL, and 1.5-fold higher than in group I, in which the content was 4.1 (2.3; 8.4) ng/mL (p < 0.05). Fasting glucose tended to increase in both groups I and II, reaching 5.0 (4.8; 5.4) mmol/L and 5.4 (4.7; 6.2) mmol/L, respectively, versus 4.4 (4.1; 4.6) mmol/L in controls. In patients with metabolic syndrome, insulin level was 12.9 (7.7; 25.8) μIU/mL, which was 1.8-fold higher than in group I, while HOMA-IR was 3.1 (1.6; 6.0), exceeding the control value by 1.4-fold and the group I value by 2.1-fold (p < 0.05). The lipid profile in group II was characterized by total cholesterol increase to 5.22 (4.93; 5.86) mmol/L, triglycerides to 1.44 (1.29; 2.11) mmol/L, and very low-density lipoprotein cholesterol to 0.66 (0.59; 0.97) mmol/L, along with a decrease in high-density lipoprotein cholesterol to 1.17 (0.87; 1.41) mmol/L. A direct correlation was found between HOMA-IR and cortisol levels (r = +0.369; p = 0.033), as well as between leptin and HOMA-IR (r = +0.437; p = 0.005). Conclusions. In military personnel with inflammatory bowel disease, the presence of metabolic syndrome is associated with more pronounced disturbances in carbohydrate and lipid metabolism, elevated leptin levels, and the development of insulin resistance. Incorporating insulin, HOMA-IR, leptin, and cortisol assessment into the standard examination may improve early diagnosis of metabolic comorbidity and risk stratification.
- 27 May 2026
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 60 (2) , 126-132
Open AccessMetabolic profile in military personnel with inflammatory bowel disease
Background. The purpose of the study was to assess the indicators of lipid and carbohydrate metabolism, cortisol, leptin, and their relationships in military personnel with inflammatory bowel disease and metabolic syndrome. Materials and methods. The study included 40 military personnel with inflammatory bowel disease, who were divided into 2 groups: group I comprised 32 participants without metabolic syndrome, and group II included 8 patients with metabolic syndrome. The control group consisted of 10 apparently healthy individuals. Serum lipid parameters, glucose, insulin, cortisol, and leptin levels were measured. Insulin resistance was assessed using the HOMA-IR index. Results. All patients with inflammatory bowel disease demonstrated elevated serum cortisol compared to the control group (p < 0.05), with no significant difference between the study groups. Leptin levels in group II were 2.4-fold higher than in the control group, amounting to 6.25 (4.0; 16.2) ng/mL versus 2.65 (0.45; 3.9) ng/mL, and 1.5-fold higher than in group I, in which the content was 4.1 (2.3; 8.4) ng/mL (p < 0.05). Fasting glucose tended to increase in both groups I and II, reaching 5.0 (4.8; 5.4) mmol/L and 5.4 (4.7; 6.2) mmol/L, respectively, versus 4.4 (4.1; 4.6) mmol/L in controls. In patients with metabolic syndrome, insulin level was 12.9 (7.7; 25.8) μIU/mL, which was 1.8-fold higher than in group I, while HOMA-IR was 3.1 (1.6; 6.0), exceeding the control value by 1.4-fold and the group I value by 2.1-fold (p < 0.05). The lipid profile in group II was characterized by total cholesterol increase to 5.22 (4.93; 5.86) mmol/L, triglycerides to 1.44 (1.29; 2.11) mmol/L, and very low-density lipoprotein cholesterol to 0.66 (0.59; 0.97) mmol/L, along with a decrease in high-density lipoprotein cholesterol to 1.17 (0.87; 1.41) mmol/L. A direct correlation was found between HOMA-IR and cortisol levels (r = +0.369; p = 0.033), as well as between leptin and HOMA-IR (r = +0.437; p = 0.005). Conclusions. In military personnel with inflammatory bowel disease, the presence of metabolic syndrome is associated with more pronounced disturbances in carbohydrate and lipid metabolism, elevated leptin levels, and the development of insulin resistance. Incorporating insulin, HOMA-IR, leptin, and cortisol assessment into the standard examination may improve early diagnosis of metabolic comorbidity and risk stratification.
- Open Access
- 20 December 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (4) , 249-254
Intestinal microbiota and short-chain fatty acids in patients with post-COVID immune response
Background. The intestinal microbiota and its metabolites play a pivotal role in the progression of liver diseases. The COVID-19 pandemic has led to a growing number of patients with metabolic-associated steatotic liver disease (MASLD), the course of which is often complicated by microbiota imbalance, acting as a key factor in hepatic metabolic and inflammatory alterations. The purpose was to assess the quantitative and qualitative composition of colonic microbiota and its metabolites in patients with metabolic-associated steatotic liver disease and immune response to SARS-CoV-2. Materials and methods. A total of 112 patients, 75 men (66.9 %) and 37 women (33.1 %), with MASLD aged 18–73 years (mean age (46.4 ± 1.5) years) were examined. The serum level of SARS-CoV-2-specific IgG antibodies was determined using the enzyme-linked immunosorbent assay. The concentration of short-chain fatty acids in feces was measured by gas chromatography. The quantitative and species composition of colonic microbiota was studied by tenfold serial dilution (10–1–10–9) using standard elective and differential diagnostic media for the isolation of aerobic and anaerobic microorganisms. Results. Patients with MASLD and immune response to SARS-CoV-2 demonstrated pronounced alterations in the intestinal microbiota profile. Grade II dysbiosis predominated in patients who had COVID-19 and grade I dysbiosis predominated in those without a history of infection. In post-COVID-19 patients, deeper disturbances were revealed, including a decrease in Bifidobacterium (28.3 %) and Lactobacillus (70.0 %) concentrations and a higher detection rate of conditionally pathogenic Enterobacteriaceae. Conclusions. Patients with MASLD and immune response to SARS-CoV-2 exhibit significant intestinal microbiota dysbiosis and imbalance of short-chain fatty acids. These findings emphasize the importance of early diagnosis and targeted correction of gut microbiota as an integral component of therapeutic strategies in this patient population.
- 20 December 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (4) , 249-254
Open AccessIntestinal microbiota and short-chain fatty acids in patients with post-COVID immune response
Background. The intestinal microbiota and its metabolites play a pivotal role in the progression of liver diseases. The COVID-19 pandemic has led to a growing number of patients with metabolic-associated steatotic liver disease (MASLD), the course of which is often complicated by microbiota imbalance, acting as a key factor in hepatic metabolic and inflammatory alterations. The purpose was to assess the quantitative and qualitative composition of colonic microbiota and its metabolites in patients with metabolic-associated steatotic liver disease and immune response to SARS-CoV-2. Materials and methods. A total of 112 patients, 75 men (66.9 %) and 37 women (33.1 %), with MASLD aged 18–73 years (mean age (46.4 ± 1.5) years) were examined. The serum level of SARS-CoV-2-specific IgG antibodies was determined using the enzyme-linked immunosorbent assay. The concentration of short-chain fatty acids in feces was measured by gas chromatography. The quantitative and species composition of colonic microbiota was studied by tenfold serial dilution (10–1–10–9) using standard elective and differential diagnostic media for the isolation of aerobic and anaerobic microorganisms. Results. Patients with MASLD and immune response to SARS-CoV-2 demonstrated pronounced alterations in the intestinal microbiota profile. Grade II dysbiosis predominated in patients who had COVID-19 and grade I dysbiosis predominated in those without a history of infection. In post-COVID-19 patients, deeper disturbances were revealed, including a decrease in Bifidobacterium (28.3 %) and Lactobacillus (70.0 %) concentrations and a higher detection rate of conditionally pathogenic Enterobacteriaceae. Conclusions. Patients with MASLD and immune response to SARS-CoV-2 exhibit significant intestinal microbiota dysbiosis and imbalance of short-chain fatty acids. These findings emphasize the importance of early diagnosis and targeted correction of gut microbiota as an integral component of therapeutic strategies in this patient population.
- Open Access
- 20 December 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (4) , 255-262
Correlations of clinical and diagnostic indicators in patients with metabolic-associated steatotic liver disease with the immune response to SARS-CoV-2
Background. Metabolic-associated steatotic liver disease (MASLD) is one of the most common chronic liver disorders linked to systemic metabolic and inflammatory dysfunctions. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can aggravate the course of MASLD through immune and inflammatory mechanisms, emphasizing the need for a personalized diagnostic approach. The purpose was to determine the correlations between clinical and biochemical parameters, immune response, hemostatic profile, and metabolic alterations in patients with MASLD and immune response to SARS-CoV-2, in order to develop personalized diagnostic criteria. Materials and methods. A total of 105 patients with MASLD and 20 healthy controls were examined. Patients were stratified based on the presence of IgG antibodies to SARS-CoV-2. The comprehensive study included evaluation of lipid and carbohydrate metabolism, inflammatory markers (interleukin (IL) 6, IL-10, tumor necrosis factor α), hemostatic parameters, and insulin resistance index. Statistical analysis was performed using nonparametric Mann-Whitney and Kruskal-Wallis tests, and Spearman’s correlation (p < 0.05). Results. In patients with MASLD and immune response to SARS-CoV-2, moderate correlations were found between triglycerides (TG) and hepatic steatosis (r = 0.317; p < 0.01), very-low-density lipoprotein levels (r = 0.227; p < 0.05), and the atherogenic coefficient (r = 0.242; p < 0.05). The insulin resistance index (HOMA-IR) correlated positively with TG (r = 0.625; p < 0.01), while IL-6 correlated with the atherogenic coefficient (r = 0.25; p < 0.05). A negative correlation was found between mean platelet volume and nitric oxide metabolites (r = –0.332; p < 0.01). Elevated mean corpuscular hemoglobin (> 31) was observed in 55.2 % of patients and was associated with decreased NOx levels (p = 0.002) and reduced heptadecanoic acid concentrations (p = 0.005). A decrease in thrombin time (< 18.4 s) was detected in 40 % of patients and was accompanied by statistically significant changes in monounsaturated fatty acid levels (p = 0.021). Overall, post-COVID-19 patients demonstrated a 2.4-fold increase in TG, a 1.9-fold elevation in very-low-density lipoproteins, and a 1.5-fold reduction in high-density lipoproteins compared to controls (p < 0.01). Conclusions. The study confirms strong interrelations between metabolic, inflammatory, and hemostatic shifts in MASLD patients following SARS-CoV-2 infection. A personalized approach allows increasing the accuracy of assessing clinical and diagnostic indicators and predicting complications.
- 20 December 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (4) , 255-262
Open AccessCorrelations of clinical and diagnostic indicators in patients with metabolic-associated steatotic liver disease with the immune response to SARS-CoV-2
Background. Metabolic-associated steatotic liver disease (MASLD) is one of the most common chronic liver disorders linked to systemic metabolic and inflammatory dysfunctions. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can aggravate the course of MASLD through immune and inflammatory mechanisms, emphasizing the need for a personalized diagnostic approach. The purpose was to determine the correlations between clinical and biochemical parameters, immune response, hemostatic profile, and metabolic alterations in patients with MASLD and immune response to SARS-CoV-2, in order to develop personalized diagnostic criteria. Materials and methods. A total of 105 patients with MASLD and 20 healthy controls were examined. Patients were stratified based on the presence of IgG antibodies to SARS-CoV-2. The comprehensive study included evaluation of lipid and carbohydrate metabolism, inflammatory markers (interleukin (IL) 6, IL-10, tumor necrosis factor α), hemostatic parameters, and insulin resistance index. Statistical analysis was performed using nonparametric Mann-Whitney and Kruskal-Wallis tests, and Spearman’s correlation (p < 0.05). Results. In patients with MASLD and immune response to SARS-CoV-2, moderate correlations were found between triglycerides (TG) and hepatic steatosis (r = 0.317; p < 0.01), very-low-density lipoprotein levels (r = 0.227; p < 0.05), and the atherogenic coefficient (r = 0.242; p < 0.05). The insulin resistance index (HOMA-IR) correlated positively with TG (r = 0.625; p < 0.01), while IL-6 correlated with the atherogenic coefficient (r = 0.25; p < 0.05). A negative correlation was found between mean platelet volume and nitric oxide metabolites (r = –0.332; p < 0.01). Elevated mean corpuscular hemoglobin (> 31) was observed in 55.2 % of patients and was associated with decreased NOx levels (p = 0.002) and reduced heptadecanoic acid concentrations (p = 0.005). A decrease in thrombin time (< 18.4 s) was detected in 40 % of patients and was accompanied by statistically significant changes in monounsaturated fatty acid levels (p = 0.021). Overall, post-COVID-19 patients demonstrated a 2.4-fold increase in TG, a 1.9-fold elevation in very-low-density lipoproteins, and a 1.5-fold reduction in high-density lipoproteins compared to controls (p < 0.01). Conclusions. The study confirms strong interrelations between metabolic, inflammatory, and hemostatic shifts in MASLD patients following SARS-CoV-2 infection. A personalized approach allows increasing the accuracy of assessing clinical and diagnostic indicators and predicting complications.
- Open Access
- 20 December 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (4) , 276-282
The effect of anxiety on non-specific resistance indicators and cytokine profile in children with obesity
Background. Nowadays, childhood obesity is one of the most serious global health problems, which has an epidemic nature and is accompanied by long-term negative consequences for the physical and mental health of children. Scientists are studying the impact of anxiety on indicators of innate and adaptive immunity in obese children, which may contribute to a better understanding of the pathogenetic mechanisms of interaction between obesity, anxiety, and the immune system in childhood. The aim of the study was to examine indicators of non-specific resistance and cytokine profile in obese children depending on the presence of anxiety disorders. Materials and methods. We examined 55 children aged 6 to 17 years (mean age (12.00 ± 0.56) years) who were undergoing treatment in the pediatric gastroenterology department of the State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”. All of them underwent anthropometric studies to determine body mass index. The presence of anxiety disorders was assessed using the Screen for Child Anxiety Related Disorders questionnaire. Depending on the level of anxiety and body mass index, the children were divided into three groups: group I — 30 patients with obesity and at least one anxiety disorder/or increased anxiety level; group II — 15 children with obesity whose anxiety level was within the normal range and who did not have any specific anxiety disorders; group III — 10 patients with normal weight and normal anxiety levels (control group). Adaptation index (AI), which determines the level of reactivity and adaptive potential of the human body, was calculated based on the ratio of lymphocytes to segmented neutrophils. The concentration of interleukin (IL) 6, IL-10, and tumor necrosis factor α in blood serum was quantified using enzyme-linked immunosorbent assay. Results. Children with obesity and anxiety disorders showed disturbances in the cellular link of immunity in the form of a decrease in the percentage of lymphocytes and a significant decrease in the АІ ((0.57 ± 0.16) vs. (0.86 ± 0.29) in children without anxiety; p = 0.025). A direct correlation was found between the level of anxiety and IL-6 (r ≈ 0.42; p < 0.01), as well as an inverse correlation between IL-6 and AI (r ≈ –0.53; p < 0.001), confirming the activation of the pro-inflammatory response and a decrease in the adaptive potential of the immune system against the background of anxiety disorders. Conclusions. The results obtained indicate the integrated nature of pathogenetic mechanisms that combine metabolic and psychoemotional factors and can be used to improve diagnostic and therapeutic strategies in children with obesity.
- 20 December 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (4) , 276-282
Open AccessThe effect of anxiety on non-specific resistance indicators and cytokine profile in children with obesity
Background. Nowadays, childhood obesity is one of the most serious global health problems, which has an epidemic nature and is accompanied by long-term negative consequences for the physical and mental health of children. Scientists are studying the impact of anxiety on indicators of innate and adaptive immunity in obese children, which may contribute to a better understanding of the pathogenetic mechanisms of interaction between obesity, anxiety, and the immune system in childhood. The aim of the study was to examine indicators of non-specific resistance and cytokine profile in obese children depending on the presence of anxiety disorders. Materials and methods. We examined 55 children aged 6 to 17 years (mean age (12.00 ± 0.56) years) who were undergoing treatment in the pediatric gastroenterology department of the State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”. All of them underwent anthropometric studies to determine body mass index. The presence of anxiety disorders was assessed using the Screen for Child Anxiety Related Disorders questionnaire. Depending on the level of anxiety and body mass index, the children were divided into three groups: group I — 30 patients with obesity and at least one anxiety disorder/or increased anxiety level; group II — 15 children with obesity whose anxiety level was within the normal range and who did not have any specific anxiety disorders; group III — 10 patients with normal weight and normal anxiety levels (control group). Adaptation index (AI), which determines the level of reactivity and adaptive potential of the human body, was calculated based on the ratio of lymphocytes to segmented neutrophils. The concentration of interleukin (IL) 6, IL-10, and tumor necrosis factor α in blood serum was quantified using enzyme-linked immunosorbent assay. Results. Children with obesity and anxiety disorders showed disturbances in the cellular link of immunity in the form of a decrease in the percentage of lymphocytes and a significant decrease in the АІ ((0.57 ± 0.16) vs. (0.86 ± 0.29) in children without anxiety; p = 0.025). A direct correlation was found between the level of anxiety and IL-6 (r ≈ 0.42; p < 0.01), as well as an inverse correlation between IL-6 and AI (r ≈ –0.53; p < 0.001), confirming the activation of the pro-inflammatory response and a decrease in the adaptive potential of the immune system against the background of anxiety disorders. Conclusions. The results obtained indicate the integrated nature of pathogenetic mechanisms that combine metabolic and psychoemotional factors and can be used to improve diagnostic and therapeutic strategies in children with obesity.
- Open Access
- 29 September 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (3) , 174-180
Hyperleptinemia in patients with gastroesophageal reflux disease and obesity: approaches to the assessment and prevention of leptin resistance
Background. Gastroesophageal reflux disease (GERD) and obesity remain the most common comorbid pathology, which significantly affects the deterioration of the quality of life of patients. Many studies have been conducted to determine the factors contributing to the development of these diseases, but the role of leptin remains the most debatable issue. Currently, there are no clear criteria for effective assessment of leptin sensitivity in clinical settings, although some researchers consider hyperleptinemia to be a key marker of leptin resistance. The aim is to substantiate approaches to the assessment and prevention of leptin resistance in patients with GERD and obesity. Materials and methods. Sixty men with GERD and obesity were examined and divided into three groups depending on the leptin level. All patients had serum levels of tumor necrosis factor alpha, interleukin 6, leptin, insulin, total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol, atherogenic index and insulin resistance index calculated. To assess anxiety syndrome and body exhaustion, precise diagnostics was used on the CONTEC 8000GW cardiograph. Body composition analysis was performed using TANITA MC-780MA scale analyzers (Japan). Results. 38.2 % of patients with hyperleptinemia were diagnosed with anxiety syndrome, 52.9 % with exhaustion, 44.1 % with sleep disorders, and 64.7 % had a dangerous amount of visceral fat. Direct correlations of leptin with hyperinsulinemia (r = 0.316; p = 0.015), insulin resistance (r = 0.302; p = 0.020), increased levels of triglycerides (r = 0.414; p = 0.003), very low-density lipoprotein cholesterol (r = 0.381; p = 0.006) and interleukin 6 (r = 0.507; p < 0.001) were found. To assess leptin resistance, the ratio of leptin to triglyceride level was used, which in patients with GERD with degree 1 obesity was (6.07 ± 0.81) conventional units, with degree 2 obesity — (11.64 ± 1.44) conventional units, with degree 3 obesity — (14.54 ± 2.26) conventional units (F = 11.67; p < 0.0001). In the presence of a dangerous amount of visceral fat, the leptin resistance coefficient increased by 1.6 times compared to patients with GERD with a safe level of visceral fat (t = 2.80; p = 0.008). Insulin resistance was associated with a significant increase in the leptin resistance coefficient — by 2.5 times (t = 4.98; p < 0.0001). According to the results of regression analysis, it was found that the ratio of leptin to triglyceride level above 8.43 conventional units with a sensitivity of 62.9 % and a specificity of 96.0 % can be used as a minimally invasive marker for assessing leptin resistance. Conclusions. Reasoned approaches to the assessment and prevention of leptin resistance in patients with GERD and obesity will contribute to increasing the effectiveness of treatment measures.
- 29 September 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (3) , 174-180
Open AccessHyperleptinemia in patients with gastroesophageal reflux disease and obesity: approaches to the assessment and prevention of leptin resistance
Background. Gastroesophageal reflux disease (GERD) and obesity remain the most common comorbid pathology, which significantly affects the deterioration of the quality of life of patients. Many studies have been conducted to determine the factors contributing to the development of these diseases, but the role of leptin remains the most debatable issue. Currently, there are no clear criteria for effective assessment of leptin sensitivity in clinical settings, although some researchers consider hyperleptinemia to be a key marker of leptin resistance. The aim is to substantiate approaches to the assessment and prevention of leptin resistance in patients with GERD and obesity. Materials and methods. Sixty men with GERD and obesity were examined and divided into three groups depending on the leptin level. All patients had serum levels of tumor necrosis factor alpha, interleukin 6, leptin, insulin, total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol, atherogenic index and insulin resistance index calculated. To assess anxiety syndrome and body exhaustion, precise diagnostics was used on the CONTEC 8000GW cardiograph. Body composition analysis was performed using TANITA MC-780MA scale analyzers (Japan). Results. 38.2 % of patients with hyperleptinemia were diagnosed with anxiety syndrome, 52.9 % with exhaustion, 44.1 % with sleep disorders, and 64.7 % had a dangerous amount of visceral fat. Direct correlations of leptin with hyperinsulinemia (r = 0.316; p = 0.015), insulin resistance (r = 0.302; p = 0.020), increased levels of triglycerides (r = 0.414; p = 0.003), very low-density lipoprotein cholesterol (r = 0.381; p = 0.006) and interleukin 6 (r = 0.507; p < 0.001) were found. To assess leptin resistance, the ratio of leptin to triglyceride level was used, which in patients with GERD with degree 1 obesity was (6.07 ± 0.81) conventional units, with degree 2 obesity — (11.64 ± 1.44) conventional units, with degree 3 obesity — (14.54 ± 2.26) conventional units (F = 11.67; p < 0.0001). In the presence of a dangerous amount of visceral fat, the leptin resistance coefficient increased by 1.6 times compared to patients with GERD with a safe level of visceral fat (t = 2.80; p = 0.008). Insulin resistance was associated with a significant increase in the leptin resistance coefficient — by 2.5 times (t = 4.98; p < 0.0001). According to the results of regression analysis, it was found that the ratio of leptin to triglyceride level above 8.43 conventional units with a sensitivity of 62.9 % and a specificity of 96.0 % can be used as a minimally invasive marker for assessing leptin resistance. Conclusions. Reasoned approaches to the assessment and prevention of leptin resistance in patients with GERD and obesity will contribute to increasing the effectiveness of treatment measures.
- Open Access
- 29 September 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (3) , 235-242
The effect of Aqua Myrgorod Detox mineral water on the gallbladder motility and biochemical parameters of blood serum in patients with biliary dysfunction
Background. Functional biliary dysfunction is a common disorder of gallbladder motility and significantly reduces the quality of life of patients. Current therapeutic strategies remain limited, which emphasizes the need to find safe non-drug approaches. One of the promising areas is the use of mineral waters that can influence gallbladder motility, mineral balance, and oxidative stress processes. The aim is to evaluate the effect of Aqua Myrgorod Detox mineral water on gallbladder motility and serum biochemical parameters in patients with biliary dysfunction. Materials and methods. The study included 10 patients with biliary dysfunction (mean age was (48.0 ± 2.25) years). For 7–8 days, they received Aqua Myrgorod Detox mineral water in a dose of 200 ml three times a day. Before and after the course, a clinical examination, gallbladder ultrasound with determination of the volume and contractile function, as well as laboratory analysis of macro- (Ca, Mg, Na, K) and microelements (Cu, Fe) and lipid peroxidation products were performed. In addition, integral coefficients (Na/K, Ca/Mg, Cu/Fe, MDA/Mg) were calculated. Results. It was found that 10 minutes after taking mineral water, the gallbladder contraction was (19.36 ± 2.47) %, and after 50 minutes — (45.36 ± 3.02) %. After the course of therapy, all patients had bile homogenization and the disappearance of sludge. Biochemical indicators showed an increase in magnesium levels from (0.77 ± 0.04) to (0.87 ± 0.03) mmol/l, p = 0.017, a decrease in copper concentration from (19.80 ± 0.85) to (17.59 ± 0.68) μmol/l, p = 0.004, and a decrease in malondialdehyde levels from (6.63 ± 0.60) to (4.18 ± 0.30) μmol/l, p = 0.018. Correlation analysis revealed a significant decrease in the Ca/Mg (p = 0.039) and MDA/Mg ratio (p = 0.018), reflecting an increase in antioxidant potential. Conclusions. Aqua Myrgorod Detox mineral water has a pronounced cholekinetic effect, helps normalize bile echostructure, improves magnesium balance and reduces the severity of oxidative stress. A comprehensive analysis of biochemical indicators confirms the feasibility of its use as a non-drug approach in the treatment of patients with biliary dysfunction.
- 29 September 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (3) , 235-242
Open AccessThe effect of Aqua Myrgorod Detox mineral water on the gallbladder motility and biochemical parameters of blood serum in patients with biliary dysfunction
Background. Functional biliary dysfunction is a common disorder of gallbladder motility and significantly reduces the quality of life of patients. Current therapeutic strategies remain limited, which emphasizes the need to find safe non-drug approaches. One of the promising areas is the use of mineral waters that can influence gallbladder motility, mineral balance, and oxidative stress processes. The aim is to evaluate the effect of Aqua Myrgorod Detox mineral water on gallbladder motility and serum biochemical parameters in patients with biliary dysfunction. Materials and methods. The study included 10 patients with biliary dysfunction (mean age was (48.0 ± 2.25) years). For 7–8 days, they received Aqua Myrgorod Detox mineral water in a dose of 200 ml three times a day. Before and after the course, a clinical examination, gallbladder ultrasound with determination of the volume and contractile function, as well as laboratory analysis of macro- (Ca, Mg, Na, K) and microelements (Cu, Fe) and lipid peroxidation products were performed. In addition, integral coefficients (Na/K, Ca/Mg, Cu/Fe, MDA/Mg) were calculated. Results. It was found that 10 minutes after taking mineral water, the gallbladder contraction was (19.36 ± 2.47) %, and after 50 minutes — (45.36 ± 3.02) %. After the course of therapy, all patients had bile homogenization and the disappearance of sludge. Biochemical indicators showed an increase in magnesium levels from (0.77 ± 0.04) to (0.87 ± 0.03) mmol/l, p = 0.017, a decrease in copper concentration from (19.80 ± 0.85) to (17.59 ± 0.68) μmol/l, p = 0.004, and a decrease in malondialdehyde levels from (6.63 ± 0.60) to (4.18 ± 0.30) μmol/l, p = 0.018. Correlation analysis revealed a significant decrease in the Ca/Mg (p = 0.039) and MDA/Mg ratio (p = 0.018), reflecting an increase in antioxidant potential. Conclusions. Aqua Myrgorod Detox mineral water has a pronounced cholekinetic effect, helps normalize bile echostructure, improves magnesium balance and reduces the severity of oxidative stress. A comprehensive analysis of biochemical indicators confirms the feasibility of its use as a non-drug approach in the treatment of patients with biliary dysfunction.
- Open Access
- 27 June 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (2) , 114-120
Efficacy of liraglutide in patients with metabolic-associated steatotic liver disease in type 2 diabetes mellitus
Background. The increasing incidence of metabolism-associated steatotic liver disease (MASLD) and type 2 diabetes prompts physicians to improve strategies for the diagnosis, prevention, and treatment of these metabolic conditions. Objective: to investigate the effects of glucagon-like peptide-1 receptor agonist (arGLP-1) on the severity of metabolic disorders in patients with MASLD and type 2 diabetes mellitus in the dynamics of treatment. Materials and methods. The study included 30 patients aged (56.5 ± 7.8) years with MASLD and type 2 diabetes mellitus. They were prescribed liraglutide, a arGLP-1, with gradual titration to the maximum dose. To assess body composition, body composition analyzers TANITA BC-545N (Japan) were used. Serum levels of glucose, glycosylated hemoglobin (HbA1c), parameters of lipid and carbohydrate metabolism were determined. The atherogenic index was calculated according to the formula of W.T. Friedewald, the TyG, TyG-BMI, TyG-WC indices were calculated based on the obtained bioimpedance analysis data, as well as lipid and carbohydrate metabolism indicators. Statistical processing of the study results was carried out by methods of variation statistics using the software package StatSoft Statistica 10.0. Results. After treatment with arGLP-1, a significant decrease in serum glucose to physiological norm was observed in 26.7 % of patients, and a reduction in HbA1c levels — in 66.7 %. The therapy led to a reduction in body mass index in 28 (93.3 %) of 30 patients, in body fat percentage — in 25 (83.3 %), and the number of cases of visceral obesity decreased to 17 (56.7 %). After the use of arGLP-1, a positive trend was observed in the form of a 1.3-fold decrease in serum triglyceride levels to (1.64 ± 0.20) mmol/L versus (2.12 ± 0.25) mmol/L before treatment. Serum cholesterol, which was elevated in 11 patients, reduced in 6 cases after therapy. The use of liraglutide led to a reduction in the TyG, TyG-BMI, TyG-WC indices. Conclusions. In patients with MASLD and type 2 diabetes, treatment with liraglutide for 6 months contributed to a decrease in the amount of fat in body composition and a positive dynamics of carbohydrate and lipid metabolism. The determination of the TyG index is a useful indicator for assessing insulin resistance, and the TyG-BMI and TyG-WC indices are recommended to be used as an affordable alternative for monitoring the effectiveness of treatment.
- 27 June 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (2) , 114-120
Open AccessEfficacy of liraglutide in patients with metabolic-associated steatotic liver disease in type 2 diabetes mellitus
Background. The increasing incidence of metabolism-associated steatotic liver disease (MASLD) and type 2 diabetes prompts physicians to improve strategies for the diagnosis, prevention, and treatment of these metabolic conditions. Objective: to investigate the effects of glucagon-like peptide-1 receptor agonist (arGLP-1) on the severity of metabolic disorders in patients with MASLD and type 2 diabetes mellitus in the dynamics of treatment. Materials and methods. The study included 30 patients aged (56.5 ± 7.8) years with MASLD and type 2 diabetes mellitus. They were prescribed liraglutide, a arGLP-1, with gradual titration to the maximum dose. To assess body composition, body composition analyzers TANITA BC-545N (Japan) were used. Serum levels of glucose, glycosylated hemoglobin (HbA1c), parameters of lipid and carbohydrate metabolism were determined. The atherogenic index was calculated according to the formula of W.T. Friedewald, the TyG, TyG-BMI, TyG-WC indices were calculated based on the obtained bioimpedance analysis data, as well as lipid and carbohydrate metabolism indicators. Statistical processing of the study results was carried out by methods of variation statistics using the software package StatSoft Statistica 10.0. Results. After treatment with arGLP-1, a significant decrease in serum glucose to physiological norm was observed in 26.7 % of patients, and a reduction in HbA1c levels — in 66.7 %. The therapy led to a reduction in body mass index in 28 (93.3 %) of 30 patients, in body fat percentage — in 25 (83.3 %), and the number of cases of visceral obesity decreased to 17 (56.7 %). After the use of arGLP-1, a positive trend was observed in the form of a 1.3-fold decrease in serum triglyceride levels to (1.64 ± 0.20) mmol/L versus (2.12 ± 0.25) mmol/L before treatment. Serum cholesterol, which was elevated in 11 patients, reduced in 6 cases after therapy. The use of liraglutide led to a reduction in the TyG, TyG-BMI, TyG-WC indices. Conclusions. In patients with MASLD and type 2 diabetes, treatment with liraglutide for 6 months contributed to a decrease in the amount of fat in body composition and a positive dynamics of carbohydrate and lipid metabolism. The determination of the TyG index is a useful indicator for assessing insulin resistance, and the TyG-BMI and TyG-WC indices are recommended to be used as an affordable alternative for monitoring the effectiveness of treatment.
- Open Access
- 27 June 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (2) , 106-113
New approaches to diagnosis and management of patients with metabolic-associated steatotic liver disease with immune response to SARS-CоV-2
Background. The detrimental interaction of complex inflammatory pathways, which are chronically present in metabolic-associated steatotic liver disease (MASLD), can be dramatically exacerbated in the setting of COVID-19, contributing to the development of liver fibrosis. To date, there is no consensus on the use of serum parameters instead of liver biopsy as criteria for predicting the unfavorable course of MASLD in patients with an immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The purpose of the study was to optimize the diagnosis and management of patients with MASLD and an immune response to SARS-CoV-2 by identifying predictors of adverse outcome. Materials and methods. The study included 105 patients with MASLD who had an elevated level of IgG antibodies specific to SARS-CoV-2 of more than 40 BAU/ml compared to the control value, which allowed us to conclude that these patients had an immune response. The stiffness of the liver parenchyma was assessed by shear wave elastography (SWE) using an expert-class ultrasound scanner Soneus P7 (Ultrasign, Ukraine, Switzerland). All patients’ serum parameters of immunological profile, liver function, and prothrombotic environment were determined. The results were statistically analyzed using the Statistica 10 software package. Results. According to the results of SWE, 49 (46.7 %) patients had no liver fibrosis, 40 (38.1 %) were diagnosed with mild fibrosis (5.79–7.5 kPa) with an average value of (6.08 ± 0.13) kPa, and 16 (15.2 %) had moderate fibrosis (7.5–10.0 kPa) with an average value of (7.65 ± 0.38) kPa. In patients with unfavorable course of MASLD, the level of aspartate aminotransferase was (50.1 ± 14.9) U/L and was 2 times higher than in the control group — (23.4 ± 10.3) U/L (p < 0.001) and in patients without liver fibrosis — (27.0 ± 9.1) U/L (p < 0.001). In the development of unfavorable course of MASLD in patients with an immune response to SARS-CoV-2, the mean platelet volume increased by 11 % (p < 0.001) compared to the controls and group without liver fibrosis. Similar changes were found when assessing the absolute number of CD16+, namely, in patients with unfavorable course of MASLD, this indicator was (0.42 ± 0.15) · 109 c/L, which is 45 % higher than in the control group — (0.29 ± 0.21) · 109 c/L (p < 0.001) and 40 % higher than in patients without liver fibrosis — (0.30 ± 0.09) · 109 c/L (p < 0.001). In patients with MASLD and an immune response to SARS-CoV-2, the most significant correlations of liver parenchymal stiffness (based on SWE data) were observed with the absolute number of CD16+ cells (r = 0.568; p < 0.0001), aspartate aminotransferase levels (r = 0.503; p = 0.0001), and mean platelet volume (r = 0.513; p = 0.0001). According to the results of logistic regression analysis, the threshold values of predictors for adverse course of MASLD in patients with an immune response to SARS-CoV-2 were determined: absolute number of CD16+ more than 0.35 (sensitivity 82.1 %, specificity 92.9 %), aspartate aminotransferase level above 49 U/L (sensitivity 71.4 %, specificity 96.4 %) and MPV more than 8.5 fL (sensitivity 89.3 %, specificity 67.9 %). Conclusions. The management of patients with MASLD and an immune response to SARS-CoV-2 should include an assessment of the risk of adverse course of MASLD, which will allow for timely application of preventive and therapeutic measures to prevent the development of severe liver fibrosis and improve the quality of life of patients.
- 27 June 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (2) , 106-113
Open AccessNew approaches to diagnosis and management of patients with metabolic-associated steatotic liver disease with immune response to SARS-CоV-2
Background. The detrimental interaction of complex inflammatory pathways, which are chronically present in metabolic-associated steatotic liver disease (MASLD), can be dramatically exacerbated in the setting of COVID-19, contributing to the development of liver fibrosis. To date, there is no consensus on the use of serum parameters instead of liver biopsy as criteria for predicting the unfavorable course of MASLD in patients with an immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The purpose of the study was to optimize the diagnosis and management of patients with MASLD and an immune response to SARS-CoV-2 by identifying predictors of adverse outcome. Materials and methods. The study included 105 patients with MASLD who had an elevated level of IgG antibodies specific to SARS-CoV-2 of more than 40 BAU/ml compared to the control value, which allowed us to conclude that these patients had an immune response. The stiffness of the liver parenchyma was assessed by shear wave elastography (SWE) using an expert-class ultrasound scanner Soneus P7 (Ultrasign, Ukraine, Switzerland). All patients’ serum parameters of immunological profile, liver function, and prothrombotic environment were determined. The results were statistically analyzed using the Statistica 10 software package. Results. According to the results of SWE, 49 (46.7 %) patients had no liver fibrosis, 40 (38.1 %) were diagnosed with mild fibrosis (5.79–7.5 kPa) with an average value of (6.08 ± 0.13) kPa, and 16 (15.2 %) had moderate fibrosis (7.5–10.0 kPa) with an average value of (7.65 ± 0.38) kPa. In patients with unfavorable course of MASLD, the level of aspartate aminotransferase was (50.1 ± 14.9) U/L and was 2 times higher than in the control group — (23.4 ± 10.3) U/L (p < 0.001) and in patients without liver fibrosis — (27.0 ± 9.1) U/L (p < 0.001). In the development of unfavorable course of MASLD in patients with an immune response to SARS-CoV-2, the mean platelet volume increased by 11 % (p < 0.001) compared to the controls and group without liver fibrosis. Similar changes were found when assessing the absolute number of CD16+, namely, in patients with unfavorable course of MASLD, this indicator was (0.42 ± 0.15) · 109 c/L, which is 45 % higher than in the control group — (0.29 ± 0.21) · 109 c/L (p < 0.001) and 40 % higher than in patients without liver fibrosis — (0.30 ± 0.09) · 109 c/L (p < 0.001). In patients with MASLD and an immune response to SARS-CoV-2, the most significant correlations of liver parenchymal stiffness (based on SWE data) were observed with the absolute number of CD16+ cells (r = 0.568; p < 0.0001), aspartate aminotransferase levels (r = 0.503; p = 0.0001), and mean platelet volume (r = 0.513; p = 0.0001). According to the results of logistic regression analysis, the threshold values of predictors for adverse course of MASLD in patients with an immune response to SARS-CoV-2 were determined: absolute number of CD16+ more than 0.35 (sensitivity 82.1 %, specificity 92.9 %), aspartate aminotransferase level above 49 U/L (sensitivity 71.4 %, specificity 96.4 %) and MPV more than 8.5 fL (sensitivity 89.3 %, specificity 67.9 %). Conclusions. The management of patients with MASLD and an immune response to SARS-CoV-2 should include an assessment of the risk of adverse course of MASLD, which will allow for timely application of preventive and therapeutic measures to prevent the development of severe liver fibrosis and improve the quality of life of patients.
- Open Access
- 25 March 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (1) , 37-43
Evaluation of the state of small intestinal microbiota, pro- and anti-inflammatory cytokines, short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease in patients with immune response to SARS-CоV-2
Background. The intestinal microbiota and its metabolites have a significant impact on the pathophysiology of liver diseases, it plays an important role in human metabolism, supports the intestinal mucosal barrier and interacts with the immune system. The COVID-19 epidemic has led to a significant increase in the number of patients in Ukraine suffering from metabolic dysfunction-associated steatotic liver disease (MASLD). One of the unresolved problems associated with MASLD is the identification of pathogenetic links that affect the risk of rapid progression of the disease and the development of irreversible changes in the liver. An imbalance in the intestinal microbiota is a trigger for the launch of a pathological reaction in the liver. The purpose: to study the features of the content of pro- and anti-inflammatory cytokines and short-chain fatty acids in MASLD in patients with an immune response to SARS-CoV-2 depending on the small intestinal bacterial overgrowth (SIBO). Materials and methods. The study included 61 patients with MASLD, 41 men and 20 women aged 18 to 73 years, mean age (46.4 ± 1.5) years. All patients underwent determination of IgG specific to SARS-CoV-2, cytokine content (IL-6, IL-10, TNF-α) in serum by enzyme-linked immunosorbent assay. For the diagnosis of SIBO, a hydrogen breath test (HBT) with glucose was performed. Evaluation of short-chain fatty acids in faeces was performed on a chromatograph using the Guohua Zhao method. Results. In 44.3 % of patients with MASLD and an immune response to SARS-CoV-2, SIBO was diagnosed. The median value of IL-6 level in SIBO significantly exceeded the control values by 13.7 times (p < 0.001), the median of TNF-α was significantly higher by 18.5 times (p < 0.001). In SIBO group, the levels of TNF-α and IL-6 were, accordingly, 2 (p = 0.01) and 3.3 times (p = 0.004) higher compared to patients without SIBO. The median acetic acid (C2) level in the group with SIBO statistically significantly exceeded the control value by 1.5 times (p = 0.021). The median concentration of propionic acid (C3) was significantly higher by 1.4 times (p = 0.003) in the faeces of patients with SIBO than in those without it. At the same time, in the presence of SIBO, a decrease in the median of butyric acid (C4) was observed by 2.2 times (p = 0.021) compared to the group of patients without SIBO. Direct correlations were found between the levels of IgG specific to SARS-CoV-2 and TNF-α (r = 0.304, p = 0.016); the HBT index at 45 min and the level of TNF-α (r = 0.269, p = 0.041), IL-6 (r = 0.443, p = 0.002), the median of propionic acid (C3) content (r = 0.400, p = 0.006). At the same time, an inverse correlation was found between the level of butyric acid (C4) and the HBT index at 60 min (r = –0.332, p = 0.040). Conclusions. In patients with MASLD with an immune response to SARS-CoV-2 and SIBO, there was a significant increase in the production of proinflammatory cytokines, in contrast to patients without SIBO. An increased content of acetic acid and a decrease in butyric acid in the faeces of patients with MASLD with an immune response to SARS-CoV-2 in the presence of SIBO were found. Disturbance in the microbial composition of the small intestinal microbiota, hyperproduction of proinflammatory cytokines and impaired synthesis of short-chain fatty acids are distinctive features of MASLD in patients with an immune response to SARS-CoV-2.
- 25 March 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (1) , 37-43
Open AccessEvaluation of the state of small intestinal microbiota, pro- and anti-inflammatory cytokines, short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease in patients with immune response to SARS-CоV-2
Background. The intestinal microbiota and its metabolites have a significant impact on the pathophysiology of liver diseases, it plays an important role in human metabolism, supports the intestinal mucosal barrier and interacts with the immune system. The COVID-19 epidemic has led to a significant increase in the number of patients in Ukraine suffering from metabolic dysfunction-associated steatotic liver disease (MASLD). One of the unresolved problems associated with MASLD is the identification of pathogenetic links that affect the risk of rapid progression of the disease and the development of irreversible changes in the liver. An imbalance in the intestinal microbiota is a trigger for the launch of a pathological reaction in the liver. The purpose: to study the features of the content of pro- and anti-inflammatory cytokines and short-chain fatty acids in MASLD in patients with an immune response to SARS-CoV-2 depending on the small intestinal bacterial overgrowth (SIBO). Materials and methods. The study included 61 patients with MASLD, 41 men and 20 women aged 18 to 73 years, mean age (46.4 ± 1.5) years. All patients underwent determination of IgG specific to SARS-CoV-2, cytokine content (IL-6, IL-10, TNF-α) in serum by enzyme-linked immunosorbent assay. For the diagnosis of SIBO, a hydrogen breath test (HBT) with glucose was performed. Evaluation of short-chain fatty acids in faeces was performed on a chromatograph using the Guohua Zhao method. Results. In 44.3 % of patients with MASLD and an immune response to SARS-CoV-2, SIBO was diagnosed. The median value of IL-6 level in SIBO significantly exceeded the control values by 13.7 times (p < 0.001), the median of TNF-α was significantly higher by 18.5 times (p < 0.001). In SIBO group, the levels of TNF-α and IL-6 were, accordingly, 2 (p = 0.01) and 3.3 times (p = 0.004) higher compared to patients without SIBO. The median acetic acid (C2) level in the group with SIBO statistically significantly exceeded the control value by 1.5 times (p = 0.021). The median concentration of propionic acid (C3) was significantly higher by 1.4 times (p = 0.003) in the faeces of patients with SIBO than in those without it. At the same time, in the presence of SIBO, a decrease in the median of butyric acid (C4) was observed by 2.2 times (p = 0.021) compared to the group of patients without SIBO. Direct correlations were found between the levels of IgG specific to SARS-CoV-2 and TNF-α (r = 0.304, p = 0.016); the HBT index at 45 min and the level of TNF-α (r = 0.269, p = 0.041), IL-6 (r = 0.443, p = 0.002), the median of propionic acid (C3) content (r = 0.400, p = 0.006). At the same time, an inverse correlation was found between the level of butyric acid (C4) and the HBT index at 60 min (r = –0.332, p = 0.040). Conclusions. In patients with MASLD with an immune response to SARS-CoV-2 and SIBO, there was a significant increase in the production of proinflammatory cytokines, in contrast to patients without SIBO. An increased content of acetic acid and a decrease in butyric acid in the faeces of patients with MASLD with an immune response to SARS-CoV-2 in the presence of SIBO were found. Disturbance in the microbial composition of the small intestinal microbiota, hyperproduction of proinflammatory cytokines and impaired synthesis of short-chain fatty acids are distinctive features of MASLD in patients with an immune response to SARS-CoV-2.
- Open Access
- 25 March 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (1) , 8-15
Features of lipid metabolism in patients with erosive esophagitis during the period of martial law
Background. Over the past decades, the number of patients with erosive esophagitis in the world has increased. At the same time, metabolic syndrome and chronic stress are considered risk factors for the development of erosive esophagitis. The aim of the study: to determine the diagnostic significance of lipid metabolism indicators for the formation of a group at risk of developing erosive esophagitis among patients with gastroesophageal reflux disease and overweight during the period of martial law. Materials and methods. The study included 40 men with gastroesophageal reflux disease and overweight. The subjects were aged from 20 to 57 years, the average age was (42.8 ± 1.2) years. According to the results of esophagogastroduodenoscopy with narrow band imaging, 25 patients were diagnosed with erosive esophagitis, and 15 with non-erosive reflux disease. The serum levels of total cholesterol (TC), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-С) were determined in all subjects using a Stat Fax 4500 biochemical analyzer (USA). Low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C) and atherogenic index (AI) were also calculated. Results. The average group content of TC in the blood serum of patients with erosive esophagitis was 1.2 times higher compared to the control group (p = 0.0083) due to the presence of hypercholesterolemia in 36.0 % of patients. Despite the fact that the median TG content in both groups did not exceed the reference values, hypertriglyceridemia was noted in 32 % of participants with erosive esophagitis. In addition, these patients, in contrast to the control group, had a significant decrease in HDL-C levels by 1.4 times (p = 0.0042) with a simultaneous 2-fold increase in VLDL-C (p = 0.0024) and a 1.8-fold in AI (p = 0.0069). In patients with erosive esophagitis, the ratios of TG/HDL-C, LDL-C/HDL-C and TC/HDL-C were, respectively, 1.4 times (p = 0.0246), 1.3 times (p = 0.0295) and 1.2 times (p = 0.0085) higher than in patients with non-erosive reflux disease. Patients with erosive esophagitis had direct correlations between body mass index and TG/HDL-C (r = 0.47; p = 0.0003), LDL-C/HDL-C (r = 0.34; p = 0.011) and TC/HDL-C (r = 0.44; p = 0.0007). Conclusions. The diagnostic criteria for the formation of a group at risk of developing erosive esophagitis among patients with gastroesophageal reflux disease and overweight during the period of martial law are the ratios of TG/HDL-C (sensitivity 78.6 %, specificity 87.5 %), TC/HDLC (sensitivity 82.1 %, specificity 62.5 %), LDL-C/HDL-C (sensitivity 75.0 %, specificity 56.2 %). Therefore, in case of contraindications or limited access to esophagogastroduodenoscopy, it is necessary to study lipid metabolism indicators and their correlations in patients with gastroesophageal reflux disease and overweight.
- 25 March 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (1) , 8-15
Open AccessFeatures of lipid metabolism in patients with erosive esophagitis during the period of martial law
Background. Over the past decades, the number of patients with erosive esophagitis in the world has increased. At the same time, metabolic syndrome and chronic stress are considered risk factors for the development of erosive esophagitis. The aim of the study: to determine the diagnostic significance of lipid metabolism indicators for the formation of a group at risk of developing erosive esophagitis among patients with gastroesophageal reflux disease and overweight during the period of martial law. Materials and methods. The study included 40 men with gastroesophageal reflux disease and overweight. The subjects were aged from 20 to 57 years, the average age was (42.8 ± 1.2) years. According to the results of esophagogastroduodenoscopy with narrow band imaging, 25 patients were diagnosed with erosive esophagitis, and 15 with non-erosive reflux disease. The serum levels of total cholesterol (TC), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-С) were determined in all subjects using a Stat Fax 4500 biochemical analyzer (USA). Low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C) and atherogenic index (AI) were also calculated. Results. The average group content of TC in the blood serum of patients with erosive esophagitis was 1.2 times higher compared to the control group (p = 0.0083) due to the presence of hypercholesterolemia in 36.0 % of patients. Despite the fact that the median TG content in both groups did not exceed the reference values, hypertriglyceridemia was noted in 32 % of participants with erosive esophagitis. In addition, these patients, in contrast to the control group, had a significant decrease in HDL-C levels by 1.4 times (p = 0.0042) with a simultaneous 2-fold increase in VLDL-C (p = 0.0024) and a 1.8-fold in AI (p = 0.0069). In patients with erosive esophagitis, the ratios of TG/HDL-C, LDL-C/HDL-C and TC/HDL-C were, respectively, 1.4 times (p = 0.0246), 1.3 times (p = 0.0295) and 1.2 times (p = 0.0085) higher than in patients with non-erosive reflux disease. Patients with erosive esophagitis had direct correlations between body mass index and TG/HDL-C (r = 0.47; p = 0.0003), LDL-C/HDL-C (r = 0.34; p = 0.011) and TC/HDL-C (r = 0.44; p = 0.0007). Conclusions. The diagnostic criteria for the formation of a group at risk of developing erosive esophagitis among patients with gastroesophageal reflux disease and overweight during the period of martial law are the ratios of TG/HDL-C (sensitivity 78.6 %, specificity 87.5 %), TC/HDLC (sensitivity 82.1 %, specificity 62.5 %), LDL-C/HDL-C (sensitivity 75.0 %, specificity 56.2 %). Therefore, in case of contraindications or limited access to esophagogastroduodenoscopy, it is necessary to study lipid metabolism indicators and their correlations in patients with gastroesophageal reflux disease and overweight.